David Colpman
Business
Orexo
Sweden
Biography
Board member since 2015 B.Sc. Pharmacy. Other appointments: Director of Colpman Consulting Ltd since 2014. Member of the Royal Pharmaceutical Society. Board member of HRA Pharma. Advisor to Sunstone Capital. Various business development and commercial positions at Glaxo Wellcome, Novo Nordisk and Boots Pharmaceuticals. Previous appointments: Former Head of Global Business Development 2012–2014, Senior Vice President of Business Development at Shire plc 1999–2012. Does not hold any shares in Orexo, as of December 31 2016.
Research Interest
Interested in business